Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  1993-12-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0009-8981(93)90062-9PMID 8143370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.

  1992cited by this paper
• Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100.

  1990cited by this paper
• Biology of cholesterol, lipoproteins and atherosclerosis.

  1989cited by this paper
• Monoclonal antibodies to human A-I apolipoprotein and characterisation of cyanogen bromide fragments of apoA-I.

  1989cited by this paper
• Rat monoclonal antibodies to human apolipoprotein B: advantages and applications.

  1989cited by this paper
• The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B.

  1989cited by this paper
• Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100.

  1989cited by this paper
• Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function.

  1988cited by this paper
• Regional specificities of monoclonal anti-human apolipoprotein B antibodies.

  1988cited by this paper
• Human apolipoprotein B-100 heparin-binding sites.

  1987cited by this paper
• Mapping of Human Apolipoprotein B Antigenic Determinants

  1987cited by this paper
• Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies.

  1987cited by this paper
• Enzyme-linked immunosorbent assay for human plasma apolipoprotein B.

  1987cited by this paper
• Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies.

  1986cited by this paper
• Complete protein sequence and identification of structural domains of human apolipoprotein B

  1986cited by this paper
• Monoclonal antibody detects Ag polymorphism of apolipoprotein B

  1986cited by this paper
• Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100

  1986cited by this paper
• High-performance liquid chromatography of serum lipoproteins.

  1986cited by this paper
• Immunochemical Characterization of Apolipoprotein A‐I from Normal Human Plasma

  1986cited by this paper
• Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipoprotein E.

  1986cited by this paper
• Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence.

  1986cited by this paper
• Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.

  1985cited by this paper
• Lipoprotein predictors of the severity of coronary artery disease in men and women.

  1985cited by this paper
• Monoclonal antibodies can precipitate low-density lipoprotein. II. Radioimmunoassays with single and combined monoclonal antibodies for determining apolipoprotein B in serum of patients with coronary artery disease.

  1985cited by this paper
• Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

  1985cited by this paper
• Expression of Apolipoprotein B Epitopes in Very Low Density Lipoprotein Subtractions: Studies with Monoclonal Antibodies

  1984cited by this paper
• Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.

  1984cited by this paper
• Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins.

  1982cited by this paper
• Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies.

  1982cited by this paper
• Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

  1981cited by this paper
• Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats.

  1981cited by this paper
• Intermediate‐density Lipoprotein and Cholesterol‐rich Very Low Density Lipoprotein in Angiographically Determined Coronary Artery Disease

  1981cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Enzyme-linked Immunosorbent Assay for Human Plasma Apolipoprotein B

  year unknowncited by this paper

• Coingestion of Fructose with Fat Cream Exacerbates Postprandial Lipidemia Primarily by Stimulating Endogenous Non-remnant Triglyceride Secretion

  2026cites this paper
• Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease

  2025cites this paper
• Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

  2025cites this paper
• Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons.

  2025cites this paper
• Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia

  2024cites this paper
• Change in Apo B100/A1 Ratio in Children With Epilepsy on Monotherapy With Sodium Valproate, Oxcarbazepine or Levetiracetam

  2023cites this paper
• Metabolic Overlap between Alzheimer’s Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia

  2023cites this paper
• What is 'remnant cholesterol'?

  2023cites this paper
• Remnant Indices for Estimating Postprandial Lipidemia in Young Women

  2023cites this paper
• Significance of Circulating Remnant Lipoprotein Cholesterol Levels Measured by Homogeneous Assay in Patients with Type 2 Diabetes

  2023cites this paper
• ApoB48 of Chylomicrons (CM) after Fat Load are Incorporated into the Liver and Reconstituted to VLDL ApoB48 in Humans

  2023cites this paper
• Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease

  2023cites this paper
• Association between serum leptin concentrations and homeostasis model assessment-insulin resistance of 2.5 and higher in normal weight Japanese women

  2023cites this paper
• Predictability of Postprandial Lipidemia by Fasting Values in Young Women

  2023cites this paper
• Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments

  2023cites this paper
• Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults

  2022cites this paper
• Lipoprotein Assessment in the twenty-first Century.

  2022cites this paper
• Investigation on postprandial triglyceride and remnant-like particle cholesterol levels after low-fat meal ingestion in the Japanese population

  2022cites this paper
• Evaluation of atherogenic lipoprotein-cholesterol to HDL cholesterol ratio as a prognostic test for ST-segment elevation myocardial infarction

  2021cites this paper
• Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

  2021cites this paper
• Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome

  2021cites this paper
• Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review

  2021cites this paper
• Effects of Dietary Blueberry (Vaccinium ashei Reade) Leaves on Mildly Postprandial Hypertriglyceridemia.

  2020cites this paper
• Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.

  2020cites this paper
• Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome

  2020cites this paper
• Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation.

  2020cites this paper
• Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes

  2020cites this paper
• The clinical and laboratory investigation of dysbetalipoproteinemia

  2020cites this paper
• Atherogenic postprandial remnant lipoproteins—a causal lipoproteins for the initiation of obesity and atherosclerosis

  2020cites this paper
• Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestine.

  2019cites this paper
• Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.

  2019cites this paper
• Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL.

  2019cites this paper
• The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.

  2019cites this paper
• Remnant lipoproteins and atherosclerotic cardiovascular disease.

  2019cites this paper
• Pathophysiology of Diabetic Dyslipidemia

  2018cites this paper
• Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.

  2018cites this paper
• Development of a Novel Homogeneous Assay for Remnant Lipoprotein Particle Cholesterol.

  2018cites this paper
• Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia

  2018cites this paper
• A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism

  2018cites this paper
• The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

  2018cites this paper
• Increase in insulin secretion and decrease in muscle degradation by fat-free milk intake are attenuated by physical exercise.

  2018cites this paper
• Small dense low‐density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease

  2018cites this paper
• Update on the laboratory investigation of dyslipidemias.

  2018cites this paper
• Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis

  2018cites this paper
• Triglyceride is Significantly Increased in Remnant Lipoproteins After Food Intake and its Association with Lipoprotein Lipase in the Plasma

  2018cites this paper
• Patients With Systemic Lupus Erythematosus Show an Increased Arterial Stiffness That is Predicted by IgM Anti–β2‐Glycoprotein I and Small Dense High‐Density Lipoprotein Particles

  2018cites this paper
• Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.

  2017cites this paper
• VII．動脈硬化リスク・治療標的としてのTG，HDL

  2017cites this paper
• Lipoprotein lipase does not increase significantly in the postprandial plasma.

  2017cites this paper
• Postprandial Hyperlipidemia and Remnant Lipoproteins

  2017cites this paper
• Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment

  2017cites this paper
• A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis

  2017cites this paper
• A Proposal of the New Mechanism on Remnant Lipoprotein Formation and Clearance after Food Intake

  2017cites this paper
• Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome

  2017cites this paper
• A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase[S]

  2017cites this paper
• Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease.

  2017influential citation
• The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins.

  2016cites this paper
• A Comparison of the Abdominal Fat Distribution and Coronary Risk Markers in Body Mass Index-matched Subjects with and without Fatty Liver.

  2016cites this paper
• riglyceride-Rich Lipoprotein emnant Levels and Metabolism ime to Adopt These rphan Risk Factors ?

  2016cites this paper
• Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.

  2016cites this paper
• Risk Factors Relationship Between Plasma Insulin Concentration and Plasma Remnant Lipoprotein Response to an Oral Fat Load in Patients With Type 2 Diabetes

  2016cites this paper
• Lipids and apolipoproteins in cardiovascular disease

  2016cites this paper
• APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.

  2016cites this paper
• Triglycerides and Risk rognostic Value of Remnant-Like Lipoprotein article Levels in Patients With Coronary rtery Disease and Type II Diabetes Mellitus

  2016cites this paper
• Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.

  2016cites this paper
• Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.

  2016cites this paper
• Remnant lipoprotein size distribution profiling via dynamic light scattering analysis.

  2016cites this paper
• Letter to Editor: Increased Presence of Remnant Lipoprotein Cholesterol in The Hdl of Diabetic Subjects.

  2016cites this paper
• Isolation and Detection of Serum Lp-X by Immunoaffinity Separation Method

  2015cites this paper
• Impact of Remnant Lipoprotein on Coronary Plaque Components.

  2015cites this paper
• Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

  2015cites this paper
• AID-2015-0061-ver9-Guardiola_1P 1..8

  2015cites this paper
• New insights into the pathophysiology of dyslipidemia in type 2 diabetes.

  2015cites this paper
• Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.

  2015cites this paper
• Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study

  2015cites this paper
• Fasting and nonfasting triglycerides in cardiovascular and other diseases.

  2015cites this paper
• Polymorphisms in LPL, CETP, and HL Protect HIV-Infected Patients from Atherogenic Dyslipidemia in an Allele-Dose-Dependent Manner

  2015cites this paper
• Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy

  2015cites this paper
• Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions.

  2015cites this paper
• Association of intima-media thickness of carotid arteries with remnant lipoproteins in men and women.

  2015cites this paper
• Body mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men.

  2015cites this paper
• Metabolic responses to physical activity in subjects with type 1 diabetes

  2015cites this paper
• Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.

  2015cites this paper
• The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.

  2015cites this paper
• Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.

  2015cites this paper
• Effects of Aerobic Exercise on Postprandial Carbohydrate and Lipoprotein Metabolism Following Cookie Ingestion in Healthy Young Women.

  2015cites this paper
• Postprandial hypertriglyceridemia as a coronary risk factor.

  2014cites this paper
• Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease

  2014cites this paper
• Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.

  2014cites this paper
• 2型糖尿病におけるエゼチミブの小型高密度低比重リポ蛋白低下作用 トリグリセリド-リッチリポ蛋白との関係

  2014cites this paper
• Identification of molecular species of cholesteryl ester hydroperoxides in very low-density and intermediate-density lipoproteins

  2014cites this paper
• Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.

  2014cites this paper
• Apolipoprotein B-48: a unique marker of chylomicron metabolism.

  2014cites this paper
• Plasma Levels of Coronary Risk Biomarkers in Chronic Kidney Disease Patients Undergoing Maintenance Hemodialysis

  2014cites this paper
• High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome.

  2014cites this paper
• Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome

  2014cites this paper
• Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.

  2014cites this paper
• Remnant Lipoproteins: A Subfraction of Plasma Triglyceride-Rich Lipoproteins Associated with Postprandial Hyperlipidemia

  2014cites this paper
• High level of plasma remnant-like particle cholesterol may predispose to development of hypertension in normotensive subjects.

  2013cites this paper
• Skew of Plasma Low- and High-Density Lipoprotein Distributions to Less Dense Subfractions in Normotriglyceridemic Chronic Kidney Disease Patients on Maintenance Hemodialysis Treatment

  2013cites this paper